{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:09:54Z","timestamp":1790500194532,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.11.032","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:15:37Z","timestamp":1353456937000},"page":"480-486","source":"Crossref","is-referenced-by-count":54,"title":["The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas"],"prefix":"10.1016","volume":"31","author":[{"given":"Kristina M.","family":"Bacon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Kruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaden","family":"Kamhawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.11.032_bib0005","unstructured":"World Health Organization. Global Alert and Response (GAR): WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases \u2013 Leishmaniasis 2012. 2012. Available from: http:\/\/www.who.int\/csr\/resources\/publications\/CSR_ISR_2000_1leish\/en\/index.html [cited 18.05.12]."},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.032_bib0010","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1371\/journal.pntd.0000300","article-title":"The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination","volume":"2","author":"Hotez","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2012.11.032_bib0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4269\/ajtmh.2011.10-0560","article-title":"Phlebotomine vector ecology in the domestic transmission of American cutaneous leishmaniasis in Chaparral, Colombia","volume":"85","author":"Ferro","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"August (9587)","key":"10.1016\/j.vaccine.2012.11.032_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(07)61301-4","article-title":"Neglected diseases, civil conflicts, and the right to health","volume":"370","author":"Beyrer","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-7-3","article-title":"Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting","volume":"7","author":"Reithinger","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.032_bib0030","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.032_bib0035","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0035-9203(86)90243-9","article-title":"Mucosal leishmaniasis (\u201cespundia Escomel\u201d, 1911)","volume":"80","author":"Marsden","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0040","unstructured":"Leishmaniasis Burden of Disease. 2012. Available from: http:\/\/www.who.int\/leishmaniasis\/burden\/en\/ [cited 11.04.12]."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0045","series-title":"Control of the leishmaniases","author":"WHO Expert Committee on the Control of Leishmaniasis","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.032_bib0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2007.77.266","article-title":"Treatment of mucosal leishmaniasis in Latin America: systematic review","volume":"77","author":"Amato","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2012.11.032_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0365-05962011000300012","article-title":"Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review","volume":"86","author":"Almeida","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.11.032_bib0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era","volume":"9","author":"Dumonteil","year":"2009","journal-title":"Infect Genet Evol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.11.032_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum Vaccin"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.11.032_bib0075","doi-asserted-by":"crossref","first-page":"e1610","DOI":"10.1371\/journal.pntd.0001610","article-title":"KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi","volume":"6","author":"Gomes","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.11.032_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2010.00976.x","article-title":"Vaccines to combat the neglected tropical diseases","volume":"239","author":"Bethony","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fimmu.2012.00110","article-title":"The immune response to sand fly salivary proteins and its influence on Leishmania immunity","volume":"3","author":"Gomes","year":"2012","journal-title":"Front Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.11.032_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1051\/parasite\/2009163227","article-title":"A combination DNA vaccine encoding nucleoside hydrolase 36 and glycoproteine 63 protects female but not male hamsters against Leishmania mexicana","volume":"16","author":"Chale-Balboa","year":"2009","journal-title":"Parasite"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.032_bib0095","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1371\/journal.pntd.0001169","article-title":"Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia","volume":"5","author":"Tavares","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0738-081X(96)00036-3","article-title":"Natural history, clinical evolution, an the host\u2013parasite interaction in new world cutaneous leishmaniasis","volume":"14","author":"Weigle","year":"1996","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.032_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/156.1.73","article-title":"Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis","volume":"156","author":"Jones","year":"1987","journal-title":"J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.11.032_bib0110","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","article-title":"Short communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004","volume":"12","author":"Vega","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0115","unstructured":"Shepard DS. Cost-effectiveness in Health and Medicine. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. New York: Oxford University Press, 1996. J Ment Health Policy Econ 1999; 2(June (2)):91\u20132."},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.032_bib0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0102-311X2000000400013","article-title":"The epidemiology and control of leishmaniasis in Andean countries","volume":"16","author":"Davies","year":"2000","journal-title":"Cad Saude Publica"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.11.032_bib0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4269\/ajtmh.2012.11-0378","article-title":"Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period","volume":"86","author":"Jirmanus","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.032_bib0130","first-page":"16","article-title":"Characterization of cutaneous isolates of Leishmania in Colombia by isoenzyme typing and kDNA restriction analysis","volume":"70","author":"Urbano","year":"2011","journal-title":"Rev Ibero-Latinoam Parasitol"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol Ther"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.11.032_bib0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S0037-86822012000100007","article-title":"Active surveillance of American tegumentary leishmaniasis in endemic areas in rural Bolivia","volume":"45","author":"Tedesqui","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.11.032_bib0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4269\/ajtmh.2011.10-0595","article-title":"Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal disease","volume":"84","author":"Bedoya-Pacheco","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4269\/ajtmh.2010.09-0218","article-title":"Environmental risk factors for the incidence of American cutaneous leishmaniasis in a sub-Andean zone of Colombia (Chaparral, Tolima)","volume":"82","author":"Valderrama-Ardila","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.032_bib0155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4269\/ajtmh.2009.80.704","article-title":"Leishmaniasis in Bolivia: comprehensive review and current status","volume":"80","author":"Garc\u00eda","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0160","unstructured":"Brazil: Pan American Health Organization; 2007."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0165","unstructured":"Colombia: Pan American Health Organization; 2007."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0170","unstructured":"Peru: Pan American Health Organization; 2007."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0175","unstructured":"Venezuela: Pan American Health Organization (PAHO); 2007."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0180","unstructured":"Bolivia: Pan American Health Organization; 2007."},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.032_bib0185","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0190","unstructured":"Countries: Brazil. May 2012 ed.: World Health Organization, 2012."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0195","unstructured":"Countries: Bolivia (Plurinational State of). May 2012 ed.: World Health Organization; 2012."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0200","unstructured":"Countries: Colombia. May 2012 ed., 2012."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0205","unstructured":"Countries: Ecuador. May 2012 ed.: World Health Organization, 2012."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0210","unstructured":"Countries: Peru. May 2012 ed.: World Health Organization, 2012."},{"key":"10.1016\/j.vaccine.2012.11.032_bib0215","unstructured":"Countries: Venezuela (Bolivarian Republic of). May 2012 ed.: World Health Organization, 2012."},{"issue":"October (Suppl. 1)","key":"10.1016\/j.vaccine.2012.11.032_bib0220","first-page":"95","article-title":"Lutzomyia longiflocosa as suspected vector of cutaneous leishmaniasis in a focus of cutaneous leishmaniasis on the sub-andean region of Tolima department, Colombia, and the knowledge on sandflies by the inhabitants","volume":"26","author":"Pardo","year":"2006","journal-title":"Biomedica"},{"issue":"December (8)","key":"10.1016\/j.vaccine.2012.11.032_bib0225","first-page":"995","article-title":"Seasonal transmission of Leishmania (Leishmania) mexicana in the state of Campeche, Yucatan Peninsula, Mexico","volume":"98","author":"Andrade-Narvaez","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","article-title":"Clinical picture of cutaneous leishmaniases due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico","volume":"96","author":"Andrade-Narvaez","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.11.032_bib0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/168.3.709","article-title":"Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity","volume":"168","author":"Weigle","year":"1993","journal-title":"J Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.11.032_bib0240","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three Leishmania species that cause diverse human disease","volume":"39","author":"Peacock","year":"2007","journal-title":"Nat Genet"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.11.032_bib0245","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.2007.76.579","article-title":"Cross-protection against Leishmania donovani but not L. braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB\/c mice","volume":"76","author":"Tonui","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0250","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2012.11.032_bib0255","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.vaccine.2009.09.047","article-title":"Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.11.032_bib0260","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4161\/hv.6.8.11563","article-title":"Pricing of new vaccines","volume":"6","author":"Lee","year":"2010","journal-title":"Hum Vaccin"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.11.032_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4161\/hv.7.1.13740","article-title":"The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making","volume":"7","author":"Lee","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0270","doi-asserted-by":"crossref","unstructured":"Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Kinetoplastid Biol Dis 2007;6:3.","DOI":"10.1186\/1475-9292-6-3"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.032_bib0275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New world cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2012.11.032_bib0285","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0290","series-title":"Information on the epidemiology and control of the leishmaniases by country or territory","author":"Desjeux","year":"1991"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of new world cutaneouls leishmaniasis \u2013 a systematic review with a meta-analysis","volume":"47","author":"Tuon","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0300","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","article-title":"Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses","volume":"156","author":"Zerpa","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2012.11.032_bib0305","unstructured":"Control of the Leishmaniases. Geneva: World Health Organization; 2010."},{"issue":"12","key":"10.1016\/j.vaccine.2012.11.032_bib0310","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","article-title":"The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Columbia in 2004","volume":"12","author":"Vega","year":"2007","journal-title":"Trop Med Int Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T21:00:37Z","timestamp":1562360437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12016258"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}